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Advances in imaging techniques enable high resolution 3D visualisation of vascular
networks over time and reveal abnormal structural features such as twists and loops 1–6.
Quantitative descriptors of vascular networks are an active area of research 1, 2, 7 and
often focus on a single spatial resolution. Simultaneously, topological data analysis
(TDA) 8, 9, the mathematical field that studies ‘shape’ of data, has expanded from theory
to applications through advances in computation and machine learning integration.
Fully characterising the geometric, spatial and temporal tissue organisation is chal-
lenging, and its quantification is necessary to assess treatment effects. Here we show-
case TDA to analyse intravital and ultramicroscopy imaging modalities and quantify
spatio-temporal variation of twists, loops, and avascular regions (voids) in 3D vascular
networks. We propose two topological lenses to study vasculature which capture in-
herent multi-scale organisation and vessel connectivity invisible to existing methods.
This topological approach validates and quantifies known qualitative trends; specifi-
cally, dynamic changes in tortuosity and loops in response to antibodies that modulate
vessel sprouting. Using these topological descriptors, we show further how radiother-
apy alters the structure of tumour vasculature. Topological data analysis offers great
potential for relating the form and function of vascular networks, and proposing novel
biomarkers for tumour progression and treatment.
Introduction. The advent of high resolution imaging techniques has driven the develop-
ment of reconstruction algorithms, which generate exquisitely detailed 3D renderings of
biological tissues, such as tumour vascular networks 10, 11. Analyses of these images have
quantified structural features and shape, including vessel density, number of vessels and
branch points 7, fractal dimension 12, and lacunarity 13, and highlighted their relevance
for monitoring disease progression 14, 15 and treatment 6. Tumours may contain regions
of high and low vessel density 2, the latter corresponding to vascular voids which are
associated with tumour hypoxia and necrosis, and lead to reduced survival in patients
and poor responses to therapy 2. Artificial intelligence and machine learning algorithms
represent the state-of-the-art for learning how to segment images; we employ them here.
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These algorithms are also excellent at classifying data, including clinical images obtained
from cancer screening 16, provided the test datasets are sufficiently large. In contrast to the
big data on which these algorithms rely, one may want to quantify, compare, and inter-
pret the spatial organisation of tissues and their response to treatment. Here we present
a topological framework that quantifies different notions of connectivity in reconstructed
3D vascular networks, complements existing descriptors (see Figs. S26, S31) and provides
a multi-scale summary of these topological features.
Mathematically, one can describe tumour vasculature as a spatial network, i.e. nodes
embedded in three-dimensional space, connected by edges that represent blood vessel
segments. An emerging mathematical field that uses topological and geometric approaches
to quantify the “shape” of data is topological data analysis (TDA) 8, 9. A central method in
TDA is persistent homology (PH) 8, 9, 17–19. PH computes features called topological invari-
ants of the data at different spatial scales; features that persist over a wide range of spatial
scales are generally considered better to represent robust topological signals in the data.
Improved computations in PH 19 have increased the scope of its applications to include
the structure of brain arteries 20, neurons 21, airways 22, stenosis 23, zebrafish patterns 24,
contagion dynamics 25, and spatial networks 26–28. The characteristics of vascular net-
works that we study using PH features are tortuousity 1 (or ‘bendiness’), loops 1, and size
of avascular regions 2.
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Figure 1: Description of datasets. We illustrate the treatments and imaging techniques used to
generate the experimental data that we analyse. Both datasets consist of 3D stacks of tumour
vasculature images from mice undergoing different treatments (vascular targeting agents and ra-
diotherapy). Intravital data were collected from live animals observed over several days. Ultra-
microscopy data 6 were obtained from multiple tumours excised at different times after treatment
(one time point per tumour).
We analyse three-dimensional vascular networks reconstructed from microscopy
images from two different studies: intravital data and ultramicrospy data 6 (see Fig. 1).
In the intravital dataset, the same vascular networks are observed over time, providing
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a time course. The low penetration depth of intravital imaging means that only part of
the vasculature can be imaged. The intravital dataset contains control (untreated) tu-
mours and tumours subjected to either vascular targeting agents or radiation therapy.
The agents consist of antibodies DC101 29 and anti-Dll4 30, which decrease and increase
vessel sprouting respectively 7, 14, 31, 32. The irradiated tumours receive either a single dose
(1× 15 Gy) or fractionated doses (5× 3 Gy) of radiation therapy. Even though radiation
therapy is commonly used to treat tumours, observations of structural changes in the
vasculature have remained inconsistent 33. The second dataset, ultramicroscopy 6, gives
three-dimensional reconstructions of the entire tumour vasculature. The dataset includes
multiple time points (snapshot data), where we obtain one time point per tumour. The
data include control tumours and tumours treated with bevacizumab 34, a drug that in-
hibits angiogenesis and is thought to (transiently) normalise 2 tumour vasculature, i.e.
reduce structural and functional abnormalities.
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Figure 2: Schematic illustration of topological data analysis (TDA) for vascular network data.
a) We reconstruct the three-dimensional vascular network from image stacks. b) We apply the
radial filtration and the α-complex filtration. c) We compute the topological summary of the data,
which consists of a collection of barcodes 35. The horizontal axis of a barcode represents a spatial
parameter such as radial distance to the tumour centre (radial filtration) or the scale at which we
view the data (α-complex filtration). Every line in a barcode corresponds to a topological feature,
i.e. a connected component, loop, or void, in the data. In the radial filtration, we analyse the
network within the sphere (highlighted in red) and compute connected components and loops as
the sphere grows from the tumour centre outwards. In the barcodes the bars start at the radius
(measured from the tumour centre) where the corresponding connected component or loop first
enters the sphere. For a connected component, its corresponding bar ends at the radius at which it
merges with another component, i.e. it connects to another part of the vascular network within the
growing sphere. A bar representing a loop finishes at the final radius of the filtration. For voids,
we study the data at different scales using the α-complex filtration (see Methods Section 4) and the
range of a bar represents the scale values where the void is detectable. Its length is a proxy for the
volume of the void. d) We extract interpretable topological descriptors of the data from barcodes.
Topological Data Analysis. Here we present topological descriptors to quantify vascular
network characteristics across different spatial scales, and over time. We first explore
appropriate multi-scale lenses of the data, called a filtration, which feed into persistent
homology computation.
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We propose two filtrations for tumour vascular networks: the radial filtration quan-
tifies topological features with respect to the distance from the tumour centre; the α-
complex 36 filtration (see Methods Section 4) quantifies avascular tumour regions that are
devoid of blood vessels. Recall the data is embedded in 3D space. The nodes of the net-
work are branching points (i.e. points where vessels branch) and vessel nodes (i.e. other
points sampled from vessels). In the radial filtration we determine the centre of mass of
the 3D nodes and grow a sphere from the centre outwards in uniform steps. In each step
we determine the nodes located inside the growing sphere and connect two nodes when
there is a vessel between them, resulting in a growing network– the radial filtration. We
then compute the connected components and loops. For the α-complex filtration 19, 36, we
construct a sequence of nested simplicial complexes (i.e., collections of nodes, edges, tri-
angles, and tetrahedra) on the 3D nodes of the vessel network. Each edge, triangle, or
tetrahedron can be assigned a filtration value α2, which can be thought of as a proxy for
volume and which is increased to obtain the filtration on the data until forming the De-
launey triangulation 37 of the 3D nodes of the vessel network. We then compute voids in
this filtration.
PH computes topological features such as connected components (dimension 0),
loops (dimension 1), and voids (dimension 2) and how they change across different scales.
These multi-scale and multi-dimensional topological features are summarised in a bar-
code 35 (see Fig. 2). From these barcodes, we create interpretable topological descriptors
in the Results.
Results. We developed interpretable quantitative descriptors of tortuosity 20 (“bendi-
ness”), loops and voids (see Figures 2d and 3) based on the calculated topological sum-
maries of 3D tumour vasculature. The connected components (dimension 0) of the ra-
dial filtration characterise the tortuosity: a vessel with high tortuosity will intersect the
growing sphere multiple times and generate many small components which then quickly
connect as the sphere radius increases and manifest in the barcode as multiple short bars.
The tortuosity descriptor was defined as the ratio of the number of short bars in dimen-
sion 0 barcodes to the number of vessel segments. The loops descriptor was computed
from the number of bars in dimension 1 barcodes of the radial filtration and divided by
the number of vessel segments. We divided both the tortuosity and loop descriptors by
the number of vessel segments to ensure the contributions are topological. PH of the α-
filtration allowed us to identify voids, i.e. avascular tumour regions, and their volume
in the vessel networks. Long bars in the corresponding barcodes (dimension 2) repre-
sent large voids, while short bars represent small voids. The void descriptor measures
the median bar length in the barcodes. Our topological descriptors provided multiscale
information about the vascular networks that complement standard statistical measures
(see Supplementary Information, Fig. S26 and Fig. S31). We further used the radial fil-
tration to determine how the number of loops per vessel segment changes over time in
different tumour locations with respect to the tumour centre.
We validated the topological descriptors on agents with known effects on tumour
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vasculature: vascular targeting agents DC101 and anti-Dll4 in the intavital data and beva-
cizumab in the ultramicroscopy data (see Fig. 3). We found significant differences in our
topological descriptors of both datasets despite that 1) the biology in the two studies was
different, e.g. treatments, tumour types, and mouse models (see Section 2 in Methods for
description), which can influence the degree of tumour vascularisation and blood vessel
structure 38, 2) the imaging modalities are not straightforward to compare (intravital is
timecourse data and can be normalised, has high spatial resolution in the xy-plane but
low penetration depth, whereas ultramicroscopy is snapshot data at lower spatial resolu-
tion but across the whole tumour). While these technical differences led to discrepancies
in computational feasibility and interpretation (see Sections S1 and S2), we successfully
completed computations and show that our topological descriptors are meaningful for
both datasets (see also Sections S4 and S5 for statistical analysis).
Temporally and spatially, our tortuosity descriptor and the number of loops per
vessel segment succeeded in capturing the abnormality of increased sprouting in the vas-
cular networks induced by anti-Dll4 (see Fig. 3ai – ii, S7a, S9, and S10) and confirmed
the transient phenomenon of vascular normalisation 2 induced by DC101 (see Fig. 3ai
– ii). Specifically, the tortuosity descriptor captured vascular normalisation 2 days after
treatment in agreement with the literature 2 and our loop descriptor showed vessel nor-
malisation 2 – 4 days after treatment for loops, which has not been reported before. The
tortuosity of the intravital dataset appeared qualitatively consistent with the conventional
tortuosity measure mean sum of angles metric (SOAM) across the network (see Fig. S18).
Our results suggested, that the discriminatory power of the tortuosity descriptor for this
data set lies between SOAM and mean chord length ratio (CLR), another conventionally
used measure for tortuosity (see Figures S9,S18, and S17). Compared to standard mea-
sures calculated on the intravital vascular networks (see Figures S11-S16), the effect of the
treatments on the number of loops highlighted either more significant and discriminatory
differences from day 2 after treatment onwards (average vessel diameter, maximal vessel
diameter, and maximal vessel length) or higher significance on day 3 (number of vessel
segments, number of branching points, and average vessel length). In comparison to the
length-diameter ratio, the number of loops captured a more long-prolonged change in
network structure which was still visible on day 4 after treatment.
Our loop descriptor further confirmed transient normalisation effects of bevacizumab
visible 1 – 7 days after treatment (see Fig. 3bi), whereas the void descriptor captured sus-
tained effects of bevacizumab on angiogenesis (see Fig. 3bii) in the ultramicroscopy data.
These trends could not be explained by changes in tumour volume (see Fig. S27) and
therefore represented genuine structural changes in the degree of vascularisation. The
differences between the treatment groups in the ultramicroscopy dataset were significant
for all topological descriptors on day 1 and 3 after treatment (see Fig. S7). The void de-
scriptor was ideally suited for this dataset as it contains the full tumour rather than a slice
as in the intravital data (see Fig. S24).
In contrast to the ultramicroscopy data (see Fig. S29), we found spatio-temporal vari-
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ation in the number of loops in response to different treatments in the intravital data (see
Fig. 3aiii). We divided the radial filtration into different spatial intervals (corresponding
to spherical shells around the tumour centre) and observed the median number of vessel
loops per vessel segment over time in each shell, normalised by day 0 of treatment. We
again confirmed known action mechanisms of action for vascular targeting agents DC101
and anti-Dll4; anti-D114 increased sprouting predominantly from blood vessels close to
the tumour periphery, thereby leading to the formation of loops (see orange/red/brown
coloured sectors in Fig. 3aiii); whereas DC101 reduced the number of loops across the
entire vessel network (see blue coloured sectors in Fig. 3aiii).
Our topological descriptors quantified and; furthermore, elucidated the unknown
effects of single-dose and fractionated-dose irradiation treatments on vascular networks
(see Figs. 4,S7, S20, and S21). Reductions of tortuosity and the number of loops from
single-dose irradiation were apparent only on day 1 after treatment and showed great
variation across different tumours over time. Spatially, the effect of single-dose irradiation
manifested in a decrease in the number of loops in the whole tumour only on day 1 after
treatment and thereafter remained stable only very close to the tumour centre; by contrast,
the number of loops increased again in most parts of the vessel network (see Fig. 4iii).
Beneficial effects of fractionated-dose irradiation became apparent after a time lag of 2
(tortuosity) or 3 days (loops, with statistically significant difference to controls on day 4,
see Fig. S7) after initial treatment. Spatially, the number of loops decreased below the
tumour surface but increased in the tumour periphery from day 2 after initial treatment
onwards (see Fig. 4iii after start of fractionated irradiation treatment). Trends in tortuosity
and number of loops revealed changes in network structure and differ from those seen
for the approximate tumour radius (see Fig. S25).
Finally, when comparing all five treatment groups in the intravital data, we found
significant differences for tortuosity on day 2 after treatment (see Fig. S22), followed by
significant differences in the number of loops on day 3 after treatment (see Fig. S23). We
hypothesise that vascular targeting agents and radiotherapy first show effects on the level
of tortuosity before changes manifest in more complex network structures such as vessel
loops. Biologically, this can be explained by treatments having an immediate effect on
individual vessels while visable changes in network connectivity require angiogenesis to
occur, which take more time.
Conclusions. In the present work, we showcased the application of an interpretable and
powerful, multi-scale topological method to analyse highly resolved images. Our ap-
proach represents a much needed paradigm shift in the analysis of images of biological
tissues, closing the current gap between the level of detail in data from modern imag-
ing modalities, which are highly resolved over space and time, and coarse quantitative
descriptors commonly extracted from these images. We quantified, validated, and un-
covered aspects of network connectivity in tumour vasculature by exploiting the three-
dimensionality of state-of-the-art data across different scales, from small vessel loops to
large voids; such information is hidden from standard summaries. Our topological de-
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scriptors characterise tortuosity and vessel loops (radial filtration), and tumour vascu-
larisation (α-complex filtration) in a novel way, giving unprecedented quantification of
dynamic changes in the network architecture of tumour blood vessels during disease
progression and treatment. In addition to validating the known dynamic effects of vas-
cular targeting agents on vessel density, we also provided novel quantification of their
spatial location effects on the vasculature. Hitherto, we offered a multiscale topological
characterisation of the effects of radiotherapy on vasculature. The topological perspective
that we used is broadly applicable to all types of spatial networks 26. Such networks arise
across many different types of biomedical imaging applications but are also relevant in
other biological settings such as signalling networks.
Our topological descriptors form a first step towards understanding the relationship
between structure and function of the vasculature. Even with this state-of-the-art data,
ethics and financial limitations preclude the collection of more data thereby limiting the
strength of the biological conclusions that can be drawn. If more data were available, our
topological descriptors could further feed directly into machine learning algorithms and
analysis. In future work, it would be interesting to perform intravital imaging followed by
ultramicroscopy imaging on the same mice with small tumours to validate the method on
the same vessel networks, exclude any influences from different imaging modalities, and
work towards topological data integration. We propose that the topological descriptors
be tested with different imaging modalities used in clinic to determine their practical use
for monitoring the response of tumours to therapy.
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Figure 3: Topological descriptors extracted from tumour blood vessel networks treated with
vascular targeting agents with known effects. a) Intravital data results. We normalised all de-
scriptors with respect to values on the day on which treatment is administered or, for controls,
the day on which observations commence (day 0). Data was collected from controls (beige), and
tumours treated with vascular targeting agent DC101 29 (dark pink), or vascular targeting agent
anti-Dll4 30 (light pink). (i) Tortuosity was computed as the ratio of short bars in dimension 0 bar-
codes of the radial filtration (≤ 10% of maximal radius used) to the number of vessel segments.
(ii) Loops are the number of bars in dimension 1 barcodes of the radial filtration per vessel seg-
ment. (iii) Spatio-temporal resolution of the number of loops per vessel segment. We illustrate
the changes in the median number of loops (normalised by day 0) in radial intervals around the
tumour centres over the days of observation. We point to the day following treatment with vas-
cular targeting agents with a cartoon drug. b) Ultramicroscopy data results. Due to the snapshot
nature of the data (one time point per tumour), all reported topological descriptors are raw values.
Data was collected from controls (beige) and tumours treated with bevacizumab (purple). (i) We
computed the number of vessel loops per vessel segment. (ii) We determined the size of voids
(avascular regions) by computing the median length of bars in the dimension 2 barcodes of the
α-complex filtration.
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Figure 4: Topological descriptors extracted from tumour blood vessel networks treated with
radiation therapy. We normalised all descriptors with respect to values on the day on which
treatment is administered (day 0) or, for controls, the day on which observations commence (day
0). Data was collected from control mice (beige), mice treated with fractionated irradiation (FIR,
brown), and mice treated with single dose irradiation (IR, blue). (i) Tortuosity was computed as
the ratio of short bars (≤ 10% of maximal radius used in the radial filtration) in the dimension 0
barcodes of the radial filtration to the number of vessel segments. (ii) Loops are the number of
bars in the dimension 1 barcodes of the radial filtration per vessel segment in the network. (iii)
Spatio-temporal resolution of the number of loops per vessel segment. We illustrate the changes
in the median number of loops (normalised by day 0) in different radial intervals around the
tumour centres over the days of observation. The yellow arrows highlight days for which the
tumours have received treatment on the prior day (i.e. an arrow on day 1 signifies that (a dose of)
treatment was administered on day 0).
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Methods
1 Experimental procedures for intravital data
Abdominal imaging window implantation. This procedure was based on a previously
described method 4. Mice were prepared in a surgical unit, administered with inhala-
tional anaesthesia and pre-operative analgesics. Body temperature and respiration rates
were monitored throughout the procedure. A one-cm cut was made along the abdomi-
nal midline approximately 5 mm underneath the sternum followed by blunt dissection
around the cut to separate the connective tissue from the skin. A custom-made imaging
window frame (Workshop at the Department of Oncology, Oxford University) was fitted
underneath the skin. Continuous sutures were used to secure the skin to the window
frame. Approximately 2.5× 105 MC38 cells stably expressing eGFP in 5 µL containing
30% of Matrigel and 10% of Evans blue dye were injected under the connective tissue
and above the abdominal muscle layer. The chamber was then flushed with water to lyse
noninjected cells by osmotic shock, tapped dry with sterile cotton swabs and flooded with
saline. A cover glass glued on the chambers lid was secured onto the window frame. The
animals were then placed onto a heat mat for postoperative recovery, and their health and
tumour growth was monitored by visual examination.
Treatment regimes. Animals with tumours approximately 100 mm3 of the chamber were
administered with either anti-mouse VEGFR2 antibody (clone DC101 29, 27 mg/kg, BioX-
Cell), anti-mouse DLL4 antibody 30 twice per week at a dose of 5 mg/kg (in two doses on
the initial day of imaging and three days later), or one of two radiation treatments. For
the radiation treatments, mice were anaesthetised under inhalation with isoflurane and
placed in an imaging-guided small animal radiation research platform (SARRP) irradia-
tor (Xstrahl Ltd). A Cone Beam CT scan (computerised tomography) of each mouse was
obtained and the treatment was planned using Muriplan (Xstrahl Ltd). The SARRP was
used to deliver 15 Gy of X-rays (220 kVp copper filtered beam with HVL of 0.93 mmCu)
to the tumour at 2 Gy per minute. This was given either in a single dose or at 5 daily
fractionations of 3 Gy X-ray radiation to the tumour. Dosimetry of the irradiator was
performed as previously described 39.
Intravital twophoton imaging. Mice were imaged for four days following initial treat-
ment for vascular targeting agents and seven days for radiation treatment with a Zeiss
LSM 880 microscope equipped with an aesthetic vaporiser and respiratory monitoring
system. Stage and atmosphere were heated to 37 ◦C. To label perfused vessels, Quatum
dot705 solution (1 µM, Invitrogen) was infused intravenously using a motorised pump at
a rate of 0.84 µL·min−1. A modelocked MaiTai laser tuned to 920 nm was used to simul-
taneously excite eGFP, tdTomato and Qdot705. The Qdot705 signal was acquired through
a BP700/100 filter with a non-descanned detector. GaAsP detectors were used to acquire
the signal of tdTomato selected by a BP 650/45 filter and the eGFP selected by a BP525/50
filter. Images were acquired in Z-stack tile scans with a pixel size of 0.823 µm and an im-
age size per tile of 512 × 512 × 5 in x, y and z, respectively. A water immersion 20 ×
objective made for UV-VIS-IR transmission with a numerical aperture of 1 was used.
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2 Datasets
We analyse two different tumour blood vessel datasets: data obtained by multiphoton
intravital 3D imaging 3 (see above for description of experimental procedures) and data
obtained by ultramicroscopy 5. Both datasets consist of 3D stacks of images of tumour
blood vessels subjected to different experimental conditions.
Dataset I: Multiphoton intravital 3D imaging. The intravital dataset consists of tumour
vasculature images that were obtained from multiphoton intravital 3D imaging 3 of trans-
genic mice injected with murine colon adenocarcinoma cells (cell line MC38). The animals
were imaged alive and over several days using the experimental procedures described in
Section 1. The mice were divided into groups that were subjected to different experimen-
tal conditions:
1. Controls (7 mice).
2. Anti-Dll4 treated tumours (3 mice): The mice were treated using anti-Dll4 antibod-
ies 30 which block Dll4 signalling and, thereby, increase vessel sprouting. The result-
ing networks are very dense and complex.
3. DC101 treated tumours (5 mice): The mice were treated using DC101 antibodies 29
which block VEGFR-2 signalling and, thereby, reduce vessel sprouting.
4. Single-dose irradiated tumours (5 mice): The mice were treated with a single dose
of 15 Gy on the first day of imaging.
5. Dose-fractionated irradiated tumours (4 mice): The mice were treated with five
doses of 3 Gy over 5 consecutive days followed by two days of rest starting on
the first day of imaging.
In each case, we refer to the start of treatment or observation as day 0.
Dataset II: Multispectral fluorescence ultramicroscopy data. The ultramicroscopy dataset
consists of multispectral fluorescence ultramicroscopy 5 images of blood vessels of hu-
man breast cancer tumours (cell line KPL-4, HER2 positive) that were implanted into 31
immunodeficient mice. The experiments were carried out by Michael Dobosz et al. 6,
Roche Diagnostics/Institute for Biological and Medical Imaging, Helmholz Zentrum, Munich.
The mice were divided into a control group and a treatment group:
1. Controls (18 mice).
2. Anti-VEGF-A treated tumours (13 mice): The mice were treated with bevacizumab 34,
an antibody which binds to VEGF-A and, thereby, induces normalisation 2 of the
vessel networks, i.e. reduces some of their structural and functional abnormalities,
and lowers their permeability 6.
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Treatment was administered once the tumours reached a volume of approximately 60 mm3,
controls were observed accordingly. To test the effect of the treatment on drug delivery
at different time points, both controls and anti-VEGF-A treated mice were also treated
with trastuzumab 40 (anti-HER2 antibody) six hours before the tumour was extracted and
prepared for imaging. Different subgroups of tumours were imaged on day 1 (5 controls,
5 treated), day 3 (5 controls, 4 treated), day 7 (5 controls, 2 treated), and day 14 (3 con-
trols, 2 treated) after administration of bevacizumab. For more details on experimental
conditions see reference 6 (note that the dataset in reference 6 was created under the same
conditions and overlaps with the data used in this work, but the two are not identical, e.g.
the dataset in reference 6 consists of 5 controls and treated mice for day 1, 3, and 7 after
treatment each but does not include day 14 after treatment). Imaging was performed ex
vivo at a spatial resolution of 5.1µm on the xy-plane with images taken every 5.1µm in
the z-direction. Skeletonisations of the images were produced by Dobosz et al. 6 using a
custom Definiens Developer script.
3 Data preprocessing
Intravital data. Skeleton files were extracted from the imaging data by combining two
segmentation models and taking their geometric average. The skeletons were then pruned
(see reference 41, p. 165, for a full description). We extracted blood vessel networks from
skeleton files using the method VesselTree from UNET CORE.VESSEL ANALYSIS in the
PYTHON code package UNET-CORE 42. The extracted networks consist of points on vessel
branches (multiple points per vessel branch including branching points) which represent
the network nodes, and the vessels that connect them which constitute the edges of the
network. VesselTree also enables us to extract network features such as number of
vessel segments (i.e. edges of the network), number of branching points (i.e. nodes of the
network), vessel diameters, vessel lengths, and measures of tortuosity (chord-length-ratio
and sum of angles metric) for every branch point.
We exclude the following data from our analysis due to imaging and/or segmen-
tation quality: control tumour 24 2C, day 4; fractionated-dose irradiated tumour 60 1E,
day 5 onwards. For the radial filtration, due to the very high number of points in some of
the blood vessel networks, we reduce the data size by including all branching points but
sampling only every second point from every branch in the following networks: control
tumour 18 4E, day 3; control tumour 18 4E, day 4; control tumour 29 1B, day 3; control
tumour 29 1B, day 4; control tumour 34 2A, day 4; control tumour 60 2A, day 4; DC101
treated tumour 51 2C, day 1; DC101 treated tumour 54 2D, day 2; anti-Dll4 treated tu-
mour 24 2A, day 3; anti-Dll4 treated tumour 24 2A, day 4. The days listed refer to the
days after tumour treatment. For the α-complex filtration we use the full set of nodes as
input.
Ultramicroscopy data. We preprocess grey scale skeletonisation files provided in the ul-
tramicroscopy dataset from individual .tif files (one for every xy-plane slice of the ves-
sel network) to .tif stacks in uint8 format using the software IMAGEJ 43. We then convert
the .tif stacks to .nii format using the function tiff2nii.m from the MATLAB tool-
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box 44. We use the .nii files as input for our UNET-CORE 42 in our PYTHON scripts. Even
though UNET-CORE was originally trained on multiphoton intravital 3D imaging, we jus-
tify our approach by the fact that the skeletonisations are clear, high-contrast images.
Any imaging specific effects were removed by the skeletonisation process which was de-
veloped specifically for this dataset 6. We compare the number of branching points and
the number of vessel segments extracted by UNET-CORE with similar measurements ex-
tracted previously by Dobosz et al. 6 and find that these are highly correlated (see Fig.
S31). We present examples of extracted vessel networks in Fig. S32.
We note that we obtain 3D coordinates for network nodes. The distances between
these nodes scale linearly with the true distance in µm. Since we are only interested in
features with respect to their relative distance to the tumour centre, this is sufficient for
our purposes. A coordinate set true to distances could be obtained by comparing an
exemplary output network closely to microscopy images.
For the radial filtration, due to the very high number of points in these blood vessel
networks (on the order of millions of nodes in comparison with on the order of thousand
nodes in the intravital data), we reduce the point clouds for all tumours by including all
branching points but sampling only every fourth point from every branch. Despite our
reduction approaches, we were not able to run our codes on one of the treated tumour
from day 14 networks. For the α-complex filtration we use the full set of nodes as input.
4 Topological data analysis
Topological data analysis is an umbrella term used for methods that allow the study of
potentially high dimensional data using mathematical concepts from topology 45. Per-
sistent homology (PH) 8, 9, 17, 18 quantifies global topological structures (e.g., connectedness,
loops, and voids) in data.
Homology and simplicial complexes. Persistent homology is based on the topological
concept of homology (for intuitive introductions, see, for example, references 46–48; for
more formal introductions see references 49–51). Homology allows one to study shapes
and forms disregarding any changes caused by stretching or bending. One can study
the properties of a topological space by partitioning it into smaller, topologically simpler
pieces, which when reassembled include the same aggregate topological information as
the original space. Topological spaces can be very simple. Two trivial examples are the
empty set X = ∅ or a space that consists of one single point X = {x}. If we want
to capture the topological properties of the second example X = {x}, we could simply
choose a single node to represent it. However, a node or even a collection of nodes does
not allow one to capture the topological properties of more complicated spaces, such as
a 2-sphere or the surface of the earth. In such cases, one needs a simple object that car-
ries the information that the space is connected but also encloses a hole. Consider, for
example, a collection of triangles glued together to form a hollow tetrahedron; this is an
example of a mathematical object called a simplicial complex. The building blocks that one
uses to approximate topological spaces are called n-simplices which one can think of as
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generalised triangles. The parameter n indicates the dimension of the simplex. Every
n-simplex contains n + 1 independent nodes: a point is a 0-simplex, an edge is a
1-simplex, a triangle is a 2-simplex, and a (solid) tetrahedron is a 3-simplex. By
using a numbering xi of vertices, we can write a 0-simplex as [x0], a 1-simplex as [x0, x1],
a 2-simplex as [x0, x1, x2], and a 3-simplex as [x0, x1, x2, x3]. The lower-dimensional sim-
plices form so-called faces of the associated higher-dimensional objects. One combines
different simplices into a simplicial complex X to capture all different aspects of a topologi-
cal space. Two simplices that are part of a simplicial complex are allowed to intersect only
in common faces. The dimension of a simplicial complex is defined to be the dimension
of its highest-dimensional simplex. A subcollection of a simplicial complex X is called a
subcomplex of X if it forms a simplicial complex itself.
For every simplicial complex X we can define a vector space Cn(X) that is spanned
by its n-simplices with coefficients in the field Z/2Z. The elements of the vector space
Cn(X) are called n-chains. We can now define a linear map, the so-called boundary op-
erator, between vector spaces Cn(X) and Cn−1(X) which takes every n-simplex x to the
(alternating) sum of its faces, i.e. its boundary:
∂n : Cn(X)→ Cn−1(X),
x 7→
n
∑
j=0
(−1)j[x0, . . . , xj−1, xj+1, . . . , xn], (1)
i.e. in the j-th summand we omit the vertex xj from the vertices spanning the (n − 1)-
simplex. Note that the sum in Equation (1) is over the field Z/2Z where (−1) = 1, i.e.
we can omit the (−1)j term in the above equation. We can use the boundary operator to
connect all n-chains of a simplicial complex X in a sequence, the so-called chain complex
C = {Cn, ∂n}:
. . .
∂n+2−→ Cn+1 ∂n+1−→ Cn ∂n−→ Cn−1 ∂n−1−→ . . . ∂1−→ C0
c 7−→ ∂nc.
We can represent a collection of edges that are connected to form a loop in a simplicial
complex as a 1-chain, for example, [x0, x1] + [x1, x2] + · · ·+ [xj, x0]. If we apply the bound-
ary operator to this 1-chain, we obtain ∂([x0, x1] + [x1, x2] + · · ·+ [xj, x0]) = [x1]− [x0] +
[x2]− [x1] + · · ·+ [x0]− [xj] = 0. In contrast, for a collection of edges that does not form a
loop this is not the case, e.g., ∂([x0, x1]+ [x1, x2]+ · · ·+[xj−1, xj]) = [xj]− [x0] = [x0]+ [xj]
(for coefficients from Z/2Z). Chains that are in the kernel of ∂n, i.e. their boundary is
zero, are called n-cycles. One can compute that the composition of two boundary maps
yields zero, i.e.
∂n∂n+1c = 0,
since the boundary of a boundary is empty. The image im ∂n+1 of the boundary operator
is therefore a subspace of the kernel ker ∂n and its elements are called n-boundaries.
One can associate a family of vector spaces known as homology groups to a simplicial
complex X based on its cycles and boundaries. For every dimension n ≥ 0 one defines
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the nth homology group as:
Hn(X) =
ker ∂n
im ∂n+1
.
In dimension 2, the elements of the homology group H2 are called voids; in dimension 1,
the elements of the homology group H1 are called loops; in dimension 0, the elements of
the homology group H0 are called connected components. Two elements in Hn are consid-
ered to be different, if they differ by more than a boundary, i.e. if they represent different
n-dimensional holes. We then say that they belong to different homology classes.
We measure the number of n-dimensional holes of a simplicial complex by consid-
ering its nth Betti number βn:
βn = dim Hn(X) = dim ker ∂n − dim im ∂n+1.
The first three Betti numbers, β0, β1, and β2, represent, respectively, the number of con-
nected components, the number of 1-dimensional holes, and the number of 2-dimensional
holes (i.e. voids) in a simplicial complex.
Persistent homology. While homology gives information about a single simplicial com-
plex, PH allows one to study topological features across embedded sequences, so-called
filtrations, of simplicial complexes, which can be constructed from data. A filtration 9, 17, 35
of a simplicial complex X is a sequence of embedded simplicial complexes,
∅ = X0 ⊆ X1 ⊆ X2 ⊆ · · · ⊆ Xend = X ,
starting with the empty complex and ending with the entire simplicial complex X. The
simplicial complexes in the filtration are connected by inclusion maps. One can now ap-
ply an important property of homology, functoriality: any map between simplicial com-
plexes fi,j : Xi → Xj induces a map between their n-chains f˜ ni,j : Cn(Xi) → Cn(Xj)
which induces a map between their homology groups f ni,j : Hn(Xi) → Hn(Xj). In par-
ticular, this means that there exist maps between the homology groups of every simpli-
cial complex in a filtration, e.g., there are maps that relate the voids, loops or connected
components in simplicial complexes across a filtration. One can visualise topological
features such as loops or connected components across a filtration in a summary dia-
gram called a barcode 35, 52. For an appropriate choice of basis 53 of the homology groups
Hn, a barcode represents the information carried by the homology groups and the maps
f ni,j : Hn(Xi)→ Hn(Xj). A topological feature of dimension n in Hn(Xb) is born in Hn(Xb),
if it is not in the image of f nb−1,b. For example, intuitively, a loop is born in filtration step
b, if the loop appears closed in the simplicial complex Xb for the first time. A topological
feature from Hn(Xi) dies in Hn(Xd), where i < d, if d is the smallest index such that the
feature mapped to zero by f ni,d. If the topological feature is a loop, intuitively it dies in
the filtration step where it is first fully covered by triangles (or other higher-dimensional
simplices). Note that some topological features never die in a filtration, for example, we
always have one connected component in a non-empty simplicial complex that is never
15
mapped to zero. In a barcode, topological features in the filtration of a simplicial complex
are represented by half-open intervals [b, d). The lifetime of a topological feature, the so-
called persistence p, is defined as p = d− b. For topological features that persist until the
last filtration step (and beyond), the persistence is said to be infinite.
Method I: Radial filtration. We apply a radial filtration 27, 28 to the 3D vessel networks, i.e.
the collection of nodes (both branching points and points along vessel branches), their
spatial coordinates, and the edges between them. We build the filtration starting in the
tumour centre, which we approximate by the centre of mass of the points sampled from
the tumour blood vessels, e.g. the nodes of our networks. We then proceed in the follow-
ing way. We divide the maximal distance of a node in the network to the centre of mass
into 500 steps and from this construct a sequence of uniformly increasing radii. Increasing
the radial distance stepwise, each time we include all nodes within the specified radius.
If two nodes that are connected by an edge are both within the given radius, we add the
edge to our filtration. In the barcodes from this filtration we can capture tortuosity (from
connected components in dimension 0 barcodes with persistence ≤ 10 % of the maximal
radius used), loops (dimension 1) and their spatial distribution.
Method II: α-complex. On 3D data, the α-complex 19, 54 filtration builds a sequence of
nested simplicial complexes (collections of nodes, edges, triangles, and tetrahedra) whose
final element Kend is the Delauney Triangulation 37, i.e. the triangulation of the 3D con-
vex hull of the data points by tetrahedra. We build the filtration on the 3D nodes of the
vessel networks. Inductively, starting with the highest dimension (i.e. first tetradedron,
then edges), each simplex σ in Kend is assigned a filtration value given by the square of its
circumradius α in the case that the circumsphere contains no other vertices than the ver-
tices of σ; otherwise, its filtrations value is given by the minimum of the filtration values
of the higher-dimensional simplices of which σ is a face. To construct the filtration, one
includes edges, triangles, and tetrahedra up to a set filtration value which one increases
stepwise. The effect of the assignment of the filtration values is, for example, that in 2D
the long edge of a slim triangle is only included when the whole triangle is included. This
avoids the formation of cycles for slim triangles. Similarly in higher dimensions. In the
barcodes from this filtration we can capture: the degree of tumour vascularisation (from
voids, dimension 2).
Statistical analysis. We analyse the statistical significance of differences between treat-
ment groups in the tortuosity values, number of loops per vessel segment, and median
persistence of voids. We perform a pairwise Wilcoxon’s rank sum test on the ultrami-
croscopy data for each day separately to determine the statistical significance of our topo-
logical measures (see Fig. S7b). We test at significance level 0.05. For the intravital data,
we perform a Kruskal-Wallis test to determine whether at least one treatment group dif-
fers significantly from the others for the topological descriptors (see Fig. S9, S10, S20, S21,
Figures S22 – S24) as well as for standard vasculature measures (see Figures S9 – S19).
We further apply a pairwise Wilcoxon’s rank sum test between the control group and the
different treatment regimes for the topological descriptors (see Fig. S7a). We again test at
significance level 0.05 and do not correct for false discovery rate. To explore correlations
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between different types of summary descriptors for vascular networks, we compute pair-
wise Pearson correlation values for the different descriptors in both datasets separately
(see Figures S26 and S31). The standard descriptors that we include for the intravital data
set are: number of vessel segments (i.e. number of edges), number of branching points
(i.e. number of nodes), maximal vessel diameter, average vessel diameter, maximal ves-
sel length, average vessel length, average chord length ratio (clr), average sum of angles
measure (SOAM), and vessel length/diameter ratio. The standard descriptors that we in-
clude for the ultramicroscopy data set are: number of vessel segments (both as computed
by 6 and unet), number of branching points (both as computed by 6 and unet), necrotic
tumour volume as computed by 6, tumour volume as computed by 6, and vital tumour
volume as computed by 6. We perform all statistical analyses in R Studio 55, all our tests
described above are by default two-sided.
5 Implementation
We implement the radial filtration in MATLAB and use the software package JAVAPLEX 56
to compute PH on our filtration. We divide the distance from the tumour centre (centre
of mass) to the farthest away point in the blood vessel network into 500 steps to build the
radial filtration. We implement the α-complex using the GUDHI library 54.
References
1. Nagy, J. A., Chang, S.-H. & Dvorak, H. F. Why are tumour vessels abnormal and why
is it important to know? British Journal of Cancer 100, 865 – 869 (2009).
2. Goel, S. et al. Normalization of the vasculature for treatment of cancer and other
diseases. Physiological Reviews 91, 1071–1121 (2011).
3. Pittet, M. J. & Weissleder, R. Intravital imaging. Cell 147, 983–991 (2011).
4. Ritsma, L. et al. Surgical implantation of an abdominal imaging window for intravital
microscopy. Nature Protocols 8, 583 – 594 (2013).
5. Dodt, H.-U. et al. Ultramicroscopy: three-dimensional visualization of neuronal net-
works in the whole mouse brain. Nature methods 4, 331–336 (2007).
6. Dobosz, M., Ntziachristos, V., Scheuer, W. & Strobel, S. Multispectral fluorescence ul-
tramicroscopy: Three-dimensional visualization and automatic quantification of tu-
mour morphology, drug penetration, and antiangiogenic treatment response. Neopla-
sia 16, 1 – 13 (2014).
7. Vilanova, G., Colominas, I. & Gomez, H. Computational modeling of tumor-induced
angiogenesis. Archives of Computational Methods in Engineering 24, 1071–1102 (2017).
8. Edelsbrunner, H., Letscher, D. & Zomorodian, A. Topological persistence and simpli-
fication. Discrete and Computational Geometry 28, 511–533 (2002).
17
9. Carlsson, G. Topology and data. Bulletin of the American Mathematical Society 46, 255–
308 (2009).
10. Bates, R. et al. Filling large discontinuities in 3D vascular networks using skeleton-
and intensity-based information. In Navab, N., Hornegger, J., Wells, W. M. & Frangi,
A. F. (eds.) Medical Image Computing and Computer-Assisted Intervention. MICCAI 2015,
vol. 9351 of Lecture Notes in Computer Science, 157–164 (Springer, Cham, 2015).
11. Bates, R. et al. Segmentation of vasculature from fluorescently labeled endothelial
cells in multi-photon microscopy images. IEEE transactions on medical imaging 38, 1
–10 (2019).
12. Gazit, Y. et al. Fractal characteristics of tumor vascular architecture during tumor
growth and regression. Microcirculation 4, 395–402 (1997).
13. Gould, D. J., Vadakkan, T. J., Poche´, R. A. & Dickinson, M. E. Multifractal and la-
cunarity analysis of microvascular morphology and remodeling. Microcirculation 18,
136–151 (2011).
14. Ehling, J. et al. Micro-CT imaging of tumour angiogenesis: quantitative measures
describing micromorphology and vascularisation. American Journal of Pathology 184,
431 – 441 (2014).
15. Bullitt, E. et al. Vessel tortuosity and brain tumor malignancy: a blinded study. Aca-
demic Radiology 12, 1232–1240 (2005).
16. McKinney, S. M. et al. International evaluation of an ai system for breast cancer screen-
ing. Nature 577, 89–94 (2020).
17. Edelsbrunner, H. & Harer, J. L. Persistent homology — A survey. Contemporary Math-
ematics 453, 257–282 (2008).
18. Edelsbrunner, H. & Harer, J. L. Computational Topology (American Mathematical Soci-
ety, Providence R. I., 2010).
19. Otter, N., Porter, M. A., Tillmann, U., Grindrod, P. & Harrington, H. A. A roadmap
for the computation of persistent homology. European Physical Journal – Data Science
6, 1–38 (2017).
20. Bendich, P., Marron, J. S., Miller, E., Pieloch, A. & Skwerer, S. Persistent homology
analysis of brain artery trees. Annals of Applied Statistics 10, 198–218 (2016).
21. Kanari, L. et al. A topological representation of branching neuronal morphologies.
Neuroinformatics 16, 3–13 (2018).
22. Belchi, F. et al. Lung topology characteristics in patients with chronic obstructive
pulmonary disease. Scientific Reports 8, 5341 (2018).
23. Nicponski, J. & Jung, J.-H. Topological data analysis of vascular disease: A theoretical
framework (2019). BioRxiv: 637090.
18
24. McGuirl, M. R., Volkening, A. & Sandstede, B. Topological data analysis of zebrafish
patterns. Proceedings of the National Academy of Sciences 117, 5113–5124 (2020).
25. Taylor, D. et al. Topological data analysis of contagion maps for examining spreading
processes on networks. Nature Communications 6, 7723 (2015).
26. Feng, M. & Porter, M. A. Spatial applications of topological data analysis:
Cities, snowflakes, random structures, and spiders spinning under the influence.
ArXiv:2001.01872.
27. Byrne, H. M. et al. Topology characterises tumour vasculature. Mathematics Today 55,
206 – 210 (2019).
28. Stolz-Pretzer, B. J. Global and local persistent homology for the shape and classification of
biological data. Ph.D. thesis, University of Oxford (2019).
29. Kannan, P. et al. Functional parameters derived from magnetic resonance imaging re-
flect vascular morphology in preclinical tumors and in human liver metastases. Clin-
ical Cancer Research 24, 4694–4704 (2018).
30. Liu, S. K. et al. Delta-like ligand 4–notch blockade and tumor radiation response.
Journal of the National Cancer Institute 103, 1778–1798 (2011).
31. Folkman, J. Tumour angiogenesis: Therapeutic implications. The New England Journal
of Medicine 285, 1182 – 1186 (1971).
32. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144,
646 – 674 (2011).
33. Park, H. J., Griffin, R. J., Hui, S., Levitt, S. H. & Song, C. W. Radiation-induced vascu-
lar damage in tumors: implications of vascular damage in ablative hypofractionated
radiotherapy (SBRT and SRS). Radiation Research 177, 311–327 (2012).
34. Ferrara, N., Hillan, K. J., Gerber, H.-P. & Novotny, W. Discovery and development of
bevacizumab, an anti-VEGF antibody for treating cancer. Nature reviews Drug discov-
ery 3, 391–400 (2004).
35. Ghrist, R. Barcodes: The persistent topology of data. Bulletin of the American Mathe-
matical Society 45, 61–75 (2008).
36. Edelsbrunner, H. The union of balls and its dual shape. In Proceedings of the ninth
annual symposium on Computational geometry, 218–231 (1993).
37. Delauney, B. Sur la sphe`re vide. A la me´moire de Georges Voronoı¨. Bulletin de
l’Acade´mie des Sciences de l’URSS. Classe des sciences mathe´matiques et na 793 – 800 (1934).
38. Konerding, M. A. et al. Evidence for characteristic vascular patterns in solid tumours:
quantitative studies using corrosion casts. British Journal of Cancer 80, 724–732 (1999).
19
39. Hill, M. et al. The development of technology for effective respiratory-gated irradi-
ation using an image-guided small animal irradiator. Radiation research 188, 247–263
(2017).
40. Hudis, C. A. Trastuzumab—mechanism of action and use in clinical practice. New
England journal of medicine 357, 39–51 (2007).
41. Bates, R. Learning to Extract Tumour Vasculature: Techniques in Machine Learning for
Medical Image Analysis. Ph.D. thesis, University of Oxford (2017).
42. Bates, R. Russ-learn: set of tools for application and training of deep learning
methods for image segmentation and vessel analysis. Software available at https:
//ibme-gitcvs.eng.ox.ac.uk/RussellB/unet-test (software retrieved in
2018).
43. Rasband, W. Imagej. Image processing and analysis in JAVA. Software available at
https://imagej.nih.gov/ij/download.html (software retrieved in 2019).
44. Sainsbury Wellcome Centre. MATLAB toolbox for analysis of output from the soft-
ware aMAP (optimized automated mouse atlas propagation) (software retrieved
in 2019). Toolbox available at www.gatsby.ucl.ac.uk/˜test/matlabTools.
zip. See https://github.com/SainsburyWellcomeCentre/aMAP/wiki for
description.
45. Munkres, J. R. Topology (Pearson Prentice Hall, New Jersey, 2000).
46. Stolz, B. J. & Mahler, B. I. H is for homology (2016). https:
//www.maths.ox.ac.uk/about-us/life-oxford-mathematics/
oxford-mathematics-alphabet/h-homology.
47. Topaz, C. M. Self-help homology tutorial for the simple(x)-minded (2015). https:
//drive.google.com/file/d/0B3Www1z6Tm8xV3ozTmN5RE94bDg/view, ac-
cessed on 8.8.2019.
48. Sizemore, A. E., Phillips-Cremins, J. E., Ghrist, R. & Bassett, D. S. The importance of
the whole: topological data analysis for the network neuroscientist. Network Neuro-
science 3, 656 — 673 (2018).
49. Kosniowski, C. A First Course in Algebraic Topology (Cambridge University Press, Cam-
bridge, London, New York, New Rochelle, Melbourne, Sydney, 1980).
50. Hatcher, A. Algebraic topology (Cambridge University Press, Cambridge, New York,
Melbourne, Madrid, Cape Town, Singapore, Sa˜o Paulo, Delhi, Dubai, Tokyo, 2001).
51. Munkres, J. R. Elements of algebraic topology (The Benjamin/Cummings Publishing
Company, inc., Redwood City (California), Menlo Park (California), Reading (Mas-
sachusetts), Amsterdam, Don Mills (Ontario), Mexico City, Sydney, Bonn, Madrid,
Singapore, Tokyo, Bogota, Santiago, San Juan, Wokingham (United Kingdom), 1984).
20
52. Carlsson, G., Zomorodian, A., Collins, A. & Guibas, L. J. Persistence barcodes for
shapes. International Journal of Shape Modeling 11, 149–187 (2005).
53. Zomorodian, A. & Carlsson, G. Computing persistent homology. Discrete and Compu-
tational Geometry 33, 249–274 (2005).
54. Rouvreau, V. Alpha complex. In GUDHI User and Reference Manual (GUDHI Editorial
Board, 2020), 3.1.1 edn. URL https://gudhi.inria.fr/doc/3.1.1/group_
_alpha__complex.html.
55. RStudio Team. RStudio: Integrated Development Environment for R. RStudio, Inc.,
Boston, MA (2016). URL http://www.rstudio.com/.
56. Tausz, A., Vejdemo-Johansson, M. & Adams, H. JavaPlex: A research software pack-
age for persistent (co)homology. In Hong, H. & Yap, C. (eds.) Mathematical Software.
ICMS 2014, vol. 8592 of Lecture Notes in Computer Science, 129–136 (Springer, Berlin,
Heidelberg, 2014). Software available at http://appliedtopology.github.io/
javaplex/.
Acknowledgements We are very grateful to Gesine Reinert for advice on statistical analysis
of our results and Ulrike Tillmann for valuable feedback over the course of the project as well
as on the initial draft. We further thank Russell Bates, Uli Bauer, James Grogan, Nina Otter,
and Nicola Richmond for helpful discussions. BJS gratefully acknowledges EPSRC and MRC
grant (EP/G037280/1) and F. Hoffmann-La Roche AG for funding her doctoral studies. BM’s
experiments leading to these results received funding from the People Programme (Marie Curie
Actions) of the European Unions Seventh Framework Programme (FP7/2007- 2013) under REA
grant agreement No 625631. HAH gratefully acknowledges funding from an EPSRC Fellowship
(EP/K041096/1) and a Royal Society university research fellowship. BJS, HMB, and HAH are
members of the Centre for Topological Data Analysis, funded by the EPSRC grant (EP/R018472/1).
Data availability The datasets used in this study are available from the corresponding author
upon request.
Code availability Computer code used to generate results is available from the corresponding
author upon request.
Author Information BJS contributed to the design of the work, the investigation and statistical
interpretation of results, creation of software, visualisation, and writing the original draft. BM,
FL, FM, JK, and RJM contributed to the acquisition of data. HMB and HAH contributed to the
conception of the project, contextualisation of the work, and supervision. BJS, JK, FM, HMB, and
HAH contributed to writing the original draft.
Competing Interests The authors declare that they have no competing financial interests.
Correspondence Correspondence and requests for materials should be addressed to Bernadette
J Stolz (email: stolz@maths.ox.ac.uk).
21
Supplementary Information
S1 Computational differences between datasets
The differences in the biology and the imaging of our datasets led to discrepancy in com-
putational feasibility (see Table S1). In particular, the network sizes and penetration depth
of the imaging differed considerably, which significantly affected the computations for the
radial filtration. We first performed the majority of computations for the intravital data
on a IBM System x3550 M4 16 core server with 768 GB RAM over 3 months but were not
able to obtain all results. For the ultramicroscopy data as well as the remaining intravital
data, we required a Dual Intel Xeon Gold 6240M 18 core processor system with 3TB of
RAM to complete computations over further 3 months. While for the intravital data we
were able to compute the radial filtration on all networks in the dataset (in some cases
after reduction approaches for the number of nodes, see Data preprocessing in Methods
description), in the ultramicroscopy data, we were not able to obtain results for one of
the control tumours on day 14 of observation despite reducing the number of nodes (see
Data preprocessing in Methods description).
S1
Data set Branching
points
Segments
(edges)
Tumour
volume (ini-
tial day of
imaging)
Penetration
depth
Radial filtration
computation
per network
Intravital 240–10.025 260–10.060 100 mm3 300 µm Days to weeks
Ultramicroscopy 12.500–
118.000
16.700–
169.150
60 mm3 ≥ 5 mm Weeks to
months
Table S1: Summary of data sets, experimental conditions, and computational time.
S2
S2 Tortuosity in the ultramicroscopy data
The tortuosity descriptor is defined as the ratio of the number of short bars (≤ 10% of
maximal radius used in the radial filtration) in dimension 0 barcodes to the number of
vessel segments. We divided by the number of vessel segments to ensure the contribu-
tions are topological and are not masked by an increase or decrease of vasculature. How-
ever, in the case of bevacizumab in the ultramicroscopy data, the significant decrease in
number of vessel segments 6, which is also visually apparent when looking at examples
of extracted vascular networks (see Fig. S32), leads to a seemingly contradictory increase
of tortuosity (see Figure S5a). This is supported by a correlation between our tortuosity
measure and the size of voids which we observed in this dataset (see Fig. S31). When
considering the raw number of short bars without dividing by the number of vessel seg-
ments, we observe the expected effect of bevacizumab on tortuosity (see Figure S5b).
As discussed in Section S1, the vascular networks in the ultramicroscopy data are
much larger than in the intravital dataset. However, they are less well resolved in the
xy-plane (see Data description on Methods). This has two consequences on our analysis
of tortuosity: 1) the tortuosity of vessels is likely to be captured to a lesser degree than in
the intravital data, 2) the number of filtration steps needed to be able to capture tortuosity
adequately would need to be significantly higher than the 500 used in the radial filtration.
Indeed, example images from this data (see Fig. S32) do not appear to show strikingly tor-
tuous vessels. Moreover, our computation of the radial filtration in 500 steps was already
at the edge of computational feasibility (see Section S1). Thus further refinement of the
filtration is not possible. Alternatively, we can observe the coarse trends change over time
without a normalisation by the number of vessel segments as shown in Figure S5b. While
our topological descriptor therefore quantified a genuine and significant change in the
vascular networks on the ultramicrocopy data, its interpretation here needs to be made
with care.
S3 Definitions of standard tortuosity measures
Sum-of-angles-metric The sum-of-angles-metric (SOAM) was applied as a measure of
tortuosity in blood vessels by Bullit et al. 15. It is computed by summing the angles of
regularly sampled tangents along a blood vessel skeleton and can take values from zero
(straight vessel) to infinity. For tortuous vessels, the metric increases monotonically with
vessel length.
Chord-length-ratio The chord-length-ratio (clr) 41 of a blood vessel is defined as the ratio
of the distance between the branching/end points of the vessel and the length of the
vessel. The measure can take a value of at most one (straight vessel) and tends to zero for
very tortuous vessels.
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Figure S5: Tortuosity in the ultramicroscopy dataset. a) Tortuosity computed as number of short
bars (≤ 10% of maximal radius used in the radial filtration) in dimension 0 barcode per vessel
segment. b) Tortuosity computed as number of short bars (≤ 10% of maximal radius used in the
radial filtration) in dimension 0 barcode.
S4 Alternative results figures and statistical analysis
We show alternative representations of our results from the main text. In Fig. S6 we
present the results for the intravital data as mean time series for each treatment group
with error bars (standard error of the mean) to highlight that our data is dynamic over
time.
In Fig. S7 we present our results including p-values from our statistical analysis. We com-
pute the (non-exact and unadjusted) p-values for the intravital data using the R function
pairwise.wilcox.test() in RSTUDIO 55 to perform a pairwise Wilcoxon’s rank sum
test between the control group and each of the treatment groups. For the ultramicroscopy
data we use the function stat compare means() from the library ggpubr to perform
Wilcoxon’s rank sum test. All our tests are by default two-sided.
In Fig. S8 we present time-series of the spatio-temporal resolution of the intravital data.
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Figure S6: Topological descriptors extracted from tumour blood vessel networks treated with
vascular targeting agents with known effects II. a) Intravital data results. We normalised all
descriptors with respect to values on the day on which treatment is administered (day 0) or, for
controls, the day on which observations commence (day 0). Data was collected from control mice
(beige), mice treated with the vascular targeting agent DC101 29 (dark pink), mice treated with
vascular targeting agent anti-Dll4 30 (light pink), mice treated with fractionated irradiation (FIR,
brown), and mice treated with single dose irradiation (IR,blue). Tortuosity was computed as the
ratio of short bars (≤ 10% of maximal radius used in the radial filtration) in the dimension 0 bar-
codes of the radial filtration to the number of vessel segments. Loops are the number of bars in
the dimension 1 barcodes of the radial filtration per vessel segment in the network. b) Ultrami-
croscopy data results. Due to the snapshot nature of the data (one time point per tumour), all
reported topological descriptors are raw values. Data was collected from control mice (beige) and
mice treated with bevacizumab (purple). We computed tortuosity values and the number of vessel
loops per vessel segment, in the same way as for the intravital data. We also determined the size
of voids (avascular regions) by computing the median length of bars in the dimension 2 barcodes
of the α-complex filtration.
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Figure S7: Topological descriptors extracted from tumour blood vessel networks treated with
vascular targeting agents with known effects III. a) Intravital data results. We normalised all
descriptors with respect to values on the day on which treatment is administered (day 0) or, for
controls, the day on which observations commence (day 0). Data was collected from control mice
(beige), mice treated with the vascular targeting agent DC101 29 (dark pink), mice treated with
vascular targeting agent anti-Dll4 30 (light pink), mice treated with fractionated irradiation (FIR,
brown), and mice treated with single dose irradiation (IR,blue). Tortuosity was computed as the
ratio of short bars (≤ 10% of maximal radius used in the radial filtration) in the dimension 0 bar-
codes of the radial filtration to the number of vessel segments. Loops are the number of bars in
the dimension 1 barcodes of the radial filtration per vessel segment in the network. b) Ultrami-
croscopy data results. Due to the snapshot nature of the data (one time point per tumour), all
reported topological descriptors are raw values. Data was collected from control mice (beige) and
mice treated with bevacizumab (purple). We computed tortuosity values and the number of vessel
loops per vessel segment, in the same way as for the intravital data. We also determined the size
of voids (avascular regions) by computing the median length of bars in the dimension 2 barcodes
of the α-complex filtration.
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(a) Radial interval I.
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(b) Radial interval II.
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(c) Radial interval III.
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(d) Radial interval IV.
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Figure S8: Mean time series of the normalised number of loops per vessel segment for different
filtration intervals in the intravital dataset. We show the mean of the number of loops normalised
by day 0 and standard error of the mean in different radial intervals. Interval I corresponds to the
radial region closest to the tumour centre, while Interval V represents parts of the vessel network
that are farthest away from the tumour centre. We separate the treatments into two groups to
facilitate the distinction of the trends.
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S5 Additional results and statistical analysis
Intravital data: DC101 versus anti-Dll4 We present statistical analysis on the control
group and treatment groups DC101 and anti-Dll4 in the intravital data. We use the func-
tion stat compare means() from the library ggpubr to compute Kruskal-Wallis test
p-values for tortuosity (see Fig. S9), number of loops per vessel segment (see Fig. S10)
as well as the following standard measures for vascular networks: number of vessel seg-
ments (see Fig. S11), number of branching points (see Fig. S12), average vessel diameter
(see Fig. S13), maximal diameter (see Fig. S14), average (mean) vessel length (see Fig. S15),
maximal vessel length (see Fig. S16), average (mean) chord length ratio (see Fig. S17), av-
erage (mean) sum of angles metric (see Fig. S18), and length-diameter ratio (see Fig. S19).
All values are normalised by day 0 of observation/treatment and were obtained from the
PYTHON code package UNET-CORE 42.
p = 0.686 p = 0.082 p = 0.851 p = 0.395
0.7
0.9
1.1
1 2 3 4
Days since treatment
S
ho
rt
 b
ar
s 
(p
er
 s
eg
m
en
t)
Control DC101 Dll4
Tortuosity
Figure S9: Box plot showing the number of short bars in the dimension 0 barcode of the radial
filtration divided by the number of vessel segments. The values are normalised by day 0 of
initial treatment for all treatment regimes to facilitate comparisons of trends over time. We show
group level p-values according to the Kruskal-Wallis test.
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Figure S10: Box plot showing the number of bars in the dimension 1 barcode of the radial
filtration divided by the number of vessel segments. The values are normalised by day 0 of
initial treatment for all treatment regimes to facilitate comparisons of trends over time. We show
group level p-values according to the Kruskal-Wallis test.
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Figure S11: Box plot showing the number of vessel segments. The values are normalised by day
0 of initial treatment for all treatment regimes to facilitate comparisons of trends over time. We
show group level p-values according to the Kruskal-Wallis test.
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Figure S12: Box plot showing the number of branching points. The values are normalised by
day 0 of initial treatment for all treatment regimes to facilitate comparisons of trends over time.
We show group level p-values according to the Kruskal-Wallis test.
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Figure S13: Box plot showing the average (mean) vessel diameter. The values are normalised by
day 0 of initial treatment for all treatment regimes to facilitate comparisons of trends over time.
We show group level p-values according to the Kruskal-Wallis test.
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Figure S14: Box plot showing the maximal vessel diameter. The values are normalised by day
0 of initial treatment for all treatment regimes to facilitate comparisons of trends over time. We
show group level p-values according to the Kruskal-Wallis test.
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Figure S15: Box plot showing the average (mean) vessel length. The values are normalised by
day 0 of initial treatment for all treatment regimes to facilitate comparisons of trends over time.
We show group level p-values according to the Kruskal-Wallis test.
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Figure S16: Box plot showing the average (mean) vessel length. The values are normalised by
day 0 of initial treatment for all treatment regimes to facilitate comparisons of trends over time.
We show group level p-values according to the Kruskal-Wallis test.
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Figure S17: Box plot showing the average (mean) chord length ratio. The values are normalised
by day 0 of initial treatment for all treatment regimes to facilitate comparisons of trends over time.
We show group level p-values according to the Kruskal-Wallis test.
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Figure S18: Box plot showing the average (mean) sum of angles metric. The values are nor-
malised by day 0 of initial treatment for all treatment regimes to facilitate comparisons of trends
over time. We show group level p-values according to the Kruskal-Wallis test.
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Figure S19: Box plot showing the length to diameter ratio. The values are normalised by day 0 of
initial treatment for all treatment regimes to facilitate comparisons of trends over time. We show
group level p-values according to the Kruskal-Wallis test.
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Intravital data: single dose irradiation versus fractionated dose irradiation We present
statistical analysis on the control group and radiation treatment groups IR (single-dose
irradiation) and FIR (fractionated-dose irradiation) in the intravital data. We use the func-
tion stat compare means() from the library ggpubr to compute Kruskal-Wallis test p-
values for tortuosity (see Fig. S20) and number of loops per vessel segment (see Fig. S21).
All values are normalised by day 0 of observation/treatment.
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Figure S20: Box plot showing the number of short bars in the dimension 0 barcode of the radial
filtration divided by the number of vessel segments. The values are normalised by day 0 of
initial treatment for all treatment regimes to facilitate comparisons of trends over time. We show
group level p-values according to the Kruskal-Wallis test.
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Figure S21: Box plot showing the number of bars in the dimension 1 barcode of the radial
filtration divided by the number of vessel segments. The values are normalised by day 0 of
initial treatment for all treatment regimes to facilitate comparisons of trends over time. We show
group level p-values according to the Kruskal-Wallis test.
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Intravital data: all treatment groups We present statistical analysis to determine whether
at least one of the treatment groups in the intravital data behaves significantly differ-
ently to the others in Fig. S22 for our extracted tortuosity measure and in Fig. S23 for
the number of loops per vessel segment. All values are normalised by day 0 of obser-
vation/treatment. We compute the (non-exact) p-values for the using the R function
kruskal.test() to compute Kruskal-Wallis in RSTUDIO 55. We further present the
same analysis for parameters not shown in the main text, i.e. for voids in Fig. S24 and
maximal radii used in the radial filtration (i.e. an approximation of the tumour radii)
in Fig. S25. Again, all values are normalised by day 0 of observation/treatment. We
note that both of these parameters do not show significant differences between treatment
groups. In the case of the voids in the intravital dataset this can be explained by the the
low penetration depth of the imaging.
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Figure S22: Box plot showing the number of short bars in the dimension 0 barcode of the radial
filtration divided by the number of vessel segments. The values are normalised by day 0 of
initial treatment for all treatment regimes to facilitate comparisons of trends over time. We show
group level p-values according to the Kruskal-Wallis test.
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Figure S23: Box plot showing the number of bars in the dimension 1 barcode of the radial
filtration divided by the number of vessel segments. The values are normalised by day 0 of
initial treatment for all treatment regimes to facilitate comparisons of trends over time. We show
group level p-values according to the Kruskal-Wallis test.
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Figure S24: Box plot showing median persistence of bars in the dimension 2 barcode of the
α-complex filtration. The values are normalised by day 0 of initial treatment for all treatment
regimes to facilitate comparisons of trends over time. We show p-values according to the Kruskal-
Wallis test.
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Figure S25: Box plot showing the maximal radius attained in the radial filtration. The values
are normalised by day 0 of initial treatment for all treatment regimes to facilitate comparisons of
trends over time. We show p-values according to the Kruskal-Wallis test.
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Finally, we present a correlation analysis between parameters that are conventionally ex-
tracted from vascular networks and our topological parameters in Fig. S26. We com-
pute pairwise Pearson correlation using the library hmisc and plot our results includ-
ing a complete linkage clustering dendrogramme of the parameters using the library
corrplot in RSTUDIO 55.
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Figure S26: Heatmap displaying the pairwise Pearson correlation coefficients between differ-
ent vascular characteristics derived from the intravital data. The dendrogramme represents
complete linkage clustering using the Euclidean distance measure. We consider the following
vascular characteristics: number of vessel segments (i.e. number of edges), number of branching
points (i.e. number of nodes), number of vessel loops, maximal vessel diameter, maximal radius
used in the radial filtration, average vessel diameter, number of vessel loops per vessel segment,
maximal vessel length, average chord length ratio (clr), average vessel length, median persistence
of bars in dimension 2 barcodes (voids), average sum of angles measure (SOAM), number of short
bars per vessel segment in the dimension 0 barcodes, vessel length/diameter ratio. We highlight
the topological measures in orange including both the number of loops and number of loops per
vessel segment to highlight the effect of the normalisation.
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Ultramicroscopy data We present box plots of the tumour volume as determined by Do-
bosz et al. 6 in Fig. S27 and the maximal radii used in the radial filtration in Fig. S28. We
compute the (non-exact) p-values using function stat compare means from the library
ggpubr in RSTUDIO 55 to perform a pairwise Wilcoxon’s rank sum test between the con-
trol group and the treatment group. All our tests are by default two-sided. We further
show the spatio-temporal resolution of the number of loops in the ultramicroscopy data
in Fig. S29. We do not find any marked differences in either treatment group in different
spherical shells around the tumour centres.
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Figure S27: Box plot showing tumour volume as determined by Dobosz et al. 6. We show p-
values according to Wilcoxon’s rank sum test.
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Figure S28: Box plot showing the maximal radius attained in the radial filtration. We show
p-values according to Wilcoxon’s rank sum test.
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(a) Radial interval I.
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(b) Radial interval II.
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(c) Radial interval III.
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(d) Radial interval IV.
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(e) Radial interval V.
Figure S29: Number of loops per vessel segment for different filtration intervals in the ultra-
microscopy dataset. We show box plots of the number of loops per vessel segment. Interval I
corresponds to the radial region closest to the tumour centre, while Interval V represents parts of
the vessel network that are farthest away from the tumour centre. We show p-values according to
Wilcoxon’s rank sum test.
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We present the distribution of loops in the ultramicroscopy data relative to the tu-
mour radii in Fig. S30. We apply a Anderson-Darling test using the function ad.test()
from the library ksamples in RSTUDIO 55 to the different time points and treatment
groups to determine whether the samples within one groups come from a common (un-
specified) distribution. We do not find this to be the case in any of the groups for any time
point.
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Figure S30: Spatial distribution of the number of loops in the ultramicroscopy data. We show
the distribution of loops in individual tumours grouped by treatment regime (top row: bevaci-
cumab treated tumours; bottom row: control tumours) and time points (column 1: day 1 after
treatment; column 2: day 2 after treatment; column 3: day 3 after treatment; column 4: day 4 after
treatment). The horizontal axis represents the radial distance to the tumour centre normalised by
tumour radius.
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Finally, we present a correlation analysis between parameters that were extracted by Do-
boszet al. 6 and our topological parameters in Fig. S26. We also include the number of
segments and branching points determined by our extraction of the vessel networks with
UNET-CORE 42. Both of these standard parameters correlate strongly with the same pa-
rameters extracted by Doboszet al. 6. We compute pairwise Pearson correlation using
the library hmisc and plot our results including a complete linkage clustering dendro-
gramme of the parameters using the library corrplot in RSTUDIO 55.
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Figure S31: Heatmap displaying the pairwise Pearson correlation coefficients between different
vascular characteristics derived from the ultramicroscopy data. The dendrogramme represents
complete linkage clustering using the Euclidean distance measure. We consider the following
vascular characteristics: number of vessel segments as computed by 6 (segments old), number of
branching points as computed by 6 (branching points old), number of branching points as com-
puted by unet, number of vessel segments as computed by unet, number of vessel loops, necrotic
tumour volume as computed by 6, tumour volume as computed by 6, vital tumour volume as
computed by 6, maximal radius used in the radial filtration, number of vessel loops per vessel
segment, median persistence of bars in dimension 2 barcodes (voids), number of short bars per
vessel segment in the dimension 0 barcodes. We highlight the topological measures in orange in-
cluding both the number of loops and number of loops per vessel segment to highlight the effect
of the normalisation.
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S6 Example images from the ultramicroscopy data
We show example images of the vessel networks extracted from the ultramicroscopy
dataset using UNET-CORE 42 in Fig. S32.
(a) Control tumour, day 3. (b) Control tumour, day 7.
(c) Anti-VEGF-A treated tumour, day 3. (d) Anti-VEGF-A treated tumour, day 7.
Figure S32: Example images of extracted vessel networks from multispectral fluorescence ul-
tramicroscopy data coloured according to chord-length-ratio (clr) values. We can see a clear
difference between the vessel networks of the treated versus the untreated tumour on both day 3
and day 7 after treatment. Note that the collection of lines in the bottom right corner of the im-
ages corresponds to text that was present in the skeleton images in the dataset. We removed these
artefacts from our extracted point clouds manually.
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